Overview Fundamentals API Earnings EOD API Sample Code Pricing

Enzolytics Inc (ENZC PINK) stock market data APIs

$0.0017 -0(-0%) as of July 25, 2024
Price chart is built with Anychart

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.

Enzolytics Inc Financial Data Overview

0.0019
0.0017
-
0.002
0.0017
0.0014-0.0602
6 057 K
3 188 M
46 590
-0.0001
1.064
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ENZC',
Type: 'Common Stock',
Name: 'Enzolytics Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000VL8WP2',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Enzolytics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 46 590
  • EBITDA -886 773
  • Earnings Per Share -4.75
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Enzolytics Inc Earnings via APIs

  • Latest Release 2024-03-31
  • EPS/Forecast NaN

Get Enzolytics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com